As regulatory restrictions ease, researchers studying Cannabis sativa L. identify its nutritional benefits and potential in vegetarian diets while highlighting the need for clarity on the safety of some concentrated extracts.
CBD and/or THC users between 18-68 years old who avidly participate and are trained in aerobic and resistance exercise report the compounds aid in their physical recuperation, a new survey determined.
This month, the industry has encountered environmental campaign concerns, regulatory hinderance, nutrition recommendation improvements, and an abundance of research.
The CBD novel foods regulatory procedure is moving at a deathly slow pace thanks to an ill-thought through process which has left investors worried and brands in the lurch, an industry expert tells NutraIngredients.
A broad-spectrum medicinal cannabis oil is effective in significantly improving sleep quality and duration, midnight melatonin levels, as well as quality of life and mood within two weeks, in adults with insomnia, according to new research.
A new study that sampled dozens of commercially available CBD products found detectable THC levels in 64% of them. Some levels were high enough to approach therapeutic thresholds or to potentially trigger drug test failures.
The European Commission has finally agreed maximum THC limits for hemp seed products for the EU market, putting an end to internal market fragmentation.
The European Council has adopted the new Common Agricultural Policy (CAP), which restores tetrahydrocannabinol (THC) levels of hemp varieties back to 0.3%.
Two attorneys are sounding the alarm on cannabis edibles that look just like popular candy—concerned these friendly looking treats could get into the wrong hands.
Folium Biosciences has become another US-based firm to submit a Novel Foods application to the UK for its cannabidiol (CBD)-based oil in response to the 31 March deadline set by the country’s food authority.
The Association for the Cannabinoid Industry (ACI) reveals details of a three-tiered certification scheme that looks to provide safety and quality assurances for cannabidiol (CBD)-based products.
The side effects of cannabidiol (CBD) products are ‘most probably’ due to native THC contamination rather than by direct action of CBD or its chemical transformation, according to a German-led study.
The Food Safety Authority of Ireland (FSAI) has updated its recall of CBD-related foods and food supplements that have flagged up safety concerns due to the presence of delta‐9‐tetrahydrocannabinol or THC.
Retailers in the CBD space have expressed frustration at a recent survey, which finds products analysed breach food law with some posing as potential safety risks for consumers.
Italy’s Ministry of Health confirms the maximum level of tetrahydrocannabinol (THC) permitted in food supplements is set at two milligrams per kilogram (mg/kg).
The European Food Safety Authority (EFSA) warns of consequences to the heart and cardiovascular system as a result of consuming large amounts of hemp products that includes supplements, teas and energy drinks.
A synthetic form of vitamin E may be behind the spate of vaping-associated lung injuries caused as a result of smoking cannabis oil (tetrahydrocannabinol/THC) using an e-cigarette cartridge.
Athletes using cannabidiol (CBD) products should be prepared for a very real risk they could fail anti-doping tests due to contamination of banned tetrahydrocannabinol (THC), ESSNA has warned.
A cannabidiol (CBD) manufacturer is calling for greater regulatory controls after independent analyses of 31 CBD-based products found varying levels of active ingredients as well as CBD-related labelling issues.
